Lymphocytes genetically modified to express tumor antigens target dendritic cells in vivo and induce antitumor immunity
Explore this paper's citation graph
- Type
- dissertation
- Published
- 2008-03-01
- Cited by
- 0
- References
- 267
- Access
- Open access
- OpenAlex
- https://openalex.org/W21682574
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:81877339
Keywords
In vivo, Immunity, Biology, Antigen, Immunology
References
- Regulation of dendritic cell numbers and maturation by lipopolysaccharide in vivo
- LAGE‐1, a new gene with tumor specificity
- The use of melanosomal proteins in the immunotherapy of melanoma.
- Effector memory T cells, early metastasis, and survival in colorectal cancer.
- A Phase I/II Trial Testing Immunization of Hepatocellular Carcinoma Patients with Dendritic Cells Pulsed with Four α-Fetoprotein Peptides
- Peripheral blood lymphocytes as target cells of retroviral vector-mediated gene transfer.
- The interleukin-2 receptor: a target for monoclonal antibody treatment of human T-cell lymphotrophic virus I-induced adult T-cell leukemia.
- The epidemiology of acquired immunodeficiency syndrome malignancies.
- The Collected Papers of Paul Ehrlich
- Dendritic cells pulsed with hsp70-peptide complexes derived from human hepatocellular carcinoma induce specific anti-tumor immune responses.
- The concept of immunological surveillance.
- Regulation of antigen presentation and cross-presentation in the dendritic cell network: facts, hypothesis, and immunological implications.
- Rapid Peptide Turnover and Inefficient Presentation of Exogenous Antigen Critically Limit the Activation of Self-Reactive CTL by Dendritic Cells1
- The Dendritic Cell Populations of Mouse Lymph Nodes1
- A Dual-Function DNA Vaccine Encoding Carcinoembryonic Antigen and CD40 Ligand Trimer Induces T Cell-Mediated Protective Immunity Against Colon Cancer in Carcinoembryonic Antigen-Transgenic Mice1
- A ras-Mutated Peptide Targeted by CTL Infiltrating a Human Melanoma Lesion1
- Mechanisms of exogenous antigen presentation by MHC class I molecules in vitro and in vivo: implications for generating CD8+ T cell responses to infectious agents, tumors, transplants, and vaccines.
- Promiscuous gene expression in medullary thymic epithelial cells mirrors the peripheral self
- Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs
- Donor leukocyte infusion from immunized donors increases tumor vaccine efficacy after allogeneic bone marrow transplantation.
Cited by
No citing papers recorded for this paper.
Related papers
- Exosomes in cancer immunotherapy: preclinical data.
- Lymphocytes genetically modified to express tumor antigens target DCs in vivo and induce antitumor immunity.
- Engineering antitumor activity
- Specific targeting of whole lymphoma cells to dendritic cells ex vivo provides a potent antitumor vaccine
- Artificial antigen-presenting cells are superior to dendritic cells at inducing antigen-specific cytotoxic T lymphocytes.
- Fusion Hybrid of Dendritic Cells and Engineered Tumor Cells Expressing Interleukin-12 Induces Type 1 Immune Responses against Tumor
- T Cells as Vehicles for Cancer Vaccination
- Innate NKT lymphocytes confer superior adaptive immunity via tumor-capturing dendritic cells
- [Immunogenic reactivity of CTLs induced by electrofusion cells of human dendritic cells and gastric cancer cells].
- Antigen-Specific Polyclonal Cytotoxic T Lymphocytes Induced by Fusions of Dendritic Cells and Tumor Cells